Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: An ITMO group study

Author: Bajetta Emilio   Catena Laura   Fazio Nicola   Pusceddu Sara   Biondani Pamela   Blanco Giusi   Ricci Sergio   Aieta Michele   Pucci Francesca   Valente Monica   Bianco Nadia   Mauri Chiara Maria   Spada Francesca  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|120|16|2457-2463

ISSN: 0008-543X

Source: Cancer, Vol.120, Iss.16, 2014-08, pp. : 2457-2463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next